Publications by authors named "Ngo Vinh Hanh"

Hepatocellular carcinoma (HCC) is associated with increased soluble CD40 levels. This study aimed to investigate CD40's role in liver tumor progression. CD40 levels were examined in HCC patient tissues and various HCC cell lines, and their interaction with CD4T cells was studied.

View Article and Find Full Text PDF

Intracellular gap (iGap) formation in liver sinusoidal endothelial cells (LSECs) is caused by the destruction of fenestrae and appears under pathological conditions; nevertheless, their role in metastasis of cancer cells to the liver remained unexplored. We elucidated that hepatotoxin-damaged and fibrotic livers gave rise to LSECs-iGap formation, which was positively correlated with increased numbers of metastatic liver foci after intrasplenic injection of Hepa1-6 cells. Hepa1-6 cells induced interleukin-23-dependent tumor necrosis factor-α (TNF-α) secretion by LSECs and triggered LSECs-iGap formation, toward which their processes protruded to transmigrate into the liver parenchyma.

View Article and Find Full Text PDF

Factors affecting the probability of hepatocellular carcinoma (HCC) development even after sustained virological response (SVR) following anti-hepatitis C virus (HCV) therapy remain unelucidated. This study characterized the role of 16 soluble (s) immune checkpoint proteins in 168 HCV-SVR patients, with 47 developing HCC at the study end point. At baseline, high concentrations of 10 immune checkpoint proteins were found in the sera of the HCC group.

View Article and Find Full Text PDF

Pancreatic cancer is a highly challenging malignancy with extremely poor prognosis. Cytoglobin (CYGB), a hemeprotein involved in liver fibrosis and cancer development, is expressed in pericytes of all organs. Here, we examined the role of CYGB in the development of pancreatic cancer.

View Article and Find Full Text PDF

Background & Aims: Hepatic stellate cells (HSCs) are the primary cell type in liver fibrosis, a significant global health care burden. Cytoglobin (CYGB), a globin family member expressed in HSCs, inhibits HSC activation and reduces collagen production. We studied the antifibrotic properties of globin family members hemoglobin (HB), myoglobin (MB), and neuroglobin (NGB) in comparison with CYGB.

View Article and Find Full Text PDF
Article Synopsis
  • Antifibrotic therapy is crucial for treating chronic liver disease, and this study explores the role of cytoglobin (CYGB), a protein linked to liver fibrosis, particularly in hepatic stellate cells (HSCs).
  • Cygb-deficient mice showed worsened liver damage and fibrosis, while overexpressing Cygb significantly improved these conditions; researchers also created a recombinant version of CYGB that reduced reactive oxygen species (ROS) and fibrosis markers in liver cells.
  • Intravenous His-CYGB treatment in mice decreased inflammation and oxidative damage without adverse effects, suggesting its potential as a targeted antifibrotic therapy for liver diseases by modifying gene expression related to inflammation and fibrosis
View Article and Find Full Text PDF